Vaccines, blood, antisera, toxins and cultures in   Kenya

Exports In 2023, Kenya exported $163M in Vaccines, blood, antisera, toxins and cultures, making it the 37th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 7th most exported product in Kenya. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Kenya are: United States ($157M), United Kingdom ($3.95M), Zambia ($319k), Uganda ($294k), and Ethiopia ($264k).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Kenya between 2022 and 2023 were United States ($156M), United Kingdom ($3.94M), and Zambia ($183k).

Imports In 2023, Kenya imported $127M in Vaccines, blood, antisera, toxins and cultures, becoming the 83rd largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 31st most imported product in Kenya. Kenya imports Vaccines, blood, antisera, toxins and cultures primarily from: India ($44.9M), Belgium ($23.6M), United States ($16.3M), South Korea ($9.29M), and Netherlands ($9.02M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Kenya between 2022 and 2023 were Belgium ($17.5M), India ($9.65M), and Netherlands ($7.85M).